Invasive Lobular Carcinoma

Invasive lobular carcinoma or ILC is a type of breast cancer that accounts for about 10% of all breast cancer cases. It begins in the lobules, which are the glands that produce milk in the breast. Unlike other forms of breast cancer, ILC has a unique pattern of growth, which makes it challenging to detect by mammography or other imaging techniques. ILC is known for its subtle and diffuse appearance on mammograms, which can make it difficult to detect. It may not always cause a lump that can be felt during a breast self-exam, and may instead present as thickening or puckering of the breast skin. Therefore, women with a family history of breast cancer or who may be at high risk for breast cancer should undergo regular screening with MRI in addition to mammograms. Treatment for ILC usually involves surgical removal of the tumor, along with lymph nodes in the area. After surgery, chemotherapy, radiation therapy, or hormone therapy may be recommended based on the stage and aggressiveness of the cancer. The treatment plan is personalized for each individual based on the characteristics of the tumor and the patient's overall health. Research in hematology and oncology continues to explore new treatments and therapies for ILC and other types of breast cancer. Advancements in precision medicine, including the use of targeted therapies that target specific molecules or genetic mutations in cancer cells, show promising results for the future of breast cancer treatment.